Showing 13,421 - 13,440 results of 41,879 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( a point decrease ))', query time: 1.11s Refine Results
  1. 13421
  2. 13422
  3. 13423

    Evaluation of PIT effects in a disseminated peritoneal model. by Kazuhide Sato (662171)

    Published 2014
    “…<p>(A) PIT regimen. Real-time GFP fluorescence imaging was obtained at each time point indicated. …”
  4. 13424

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  5. 13425

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  6. 13426

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  7. 13427

    Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  8. 13428

    Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  9. 13429
  10. 13430
  11. 13431

    Calcium levels in PC12 cells exposed to SMF, the A<sub>2A</sub>R agonist CGS21680 or antagonist ZM241385. by Zhiyun Wang (360002)

    Published 2013
    “…<p>(<b>A</b>) Extracellular Ca<sup>2+</sup> was measured for cells maintained in calcium-free medium increased for time points up to 3.0 h in response to SMF exposure; <i>p</i><0.05 for n = 3 independent experiments. …”
  12. 13432
  13. 13433

    RNA expression of <i>KRT6, KRT10, S100A8, S100A9, p21, and HMOX-1</i>. by Emiliano Fratini (223406)

    Published 2011
    “…<i>KRT10</i> showed a tendency to decrease (statistically not significant) in all treated samples. …”
  14. 13434

    Gonadal development and sex ratios as a function of TL. by Frederic H. Martini (481487)

    Published 2013
    “…</p> <p>(b) Sex ratios (female:male) as a function of TL. Data were sorted into 50 mm TL intervals. …”
  15. 13435

    Closed loop stimulation (CLS) simulation results. by Muhammad Mushtaq (788834)

    Published 2024
    “…<p><b><i>A</i></b>, Power spectral density (PSD) of the cortical LFP across a 300 s time period with “Point 1” (green), “Point 4” stimulation (red), and Control (black) simulation. …”
  16. 13436

    Data_Sheet_1_Short Practical Regimen of Acupuncture for Melasma: A Prospective Cohort Study in a Tertiary Hospital in Thailand.PDF by Thanan Supasiri (11644450)

    Published 2021
    “…At 1 week after five sessions of acupuncture in Group A, the mean MI decreased by 28.7 (95% CI −38.5 to −18.8, p < 0.001), whereas the median MASI decreased by 3.4 (95% CI −6.9 to −1.2, p < 0.001) points. …”
  17. 13437
  18. 13438
  19. 13439

    Image1_A 12-week lifestyle intervention: effects on fatigue, fear, and nutritional status in children with a Fontan circulation.pdf by L. E. Scheffers (17339467)

    Published 2023
    “…Before training, fear regarding exercise scored on the fear thermometer was low for both children and parents (median score 1 and 2, respectively, on a scale of 0–8). After training, child-reported fear decreased further compared to the control period [effect size −1.4 points (−2.3 to −0.6), p = 0.001]. …”
  20. 13440

    Developmental changes in connectivity strength are not a function of distance. by Scott Marek (841529)

    Published 2016
    “…(B) Each point represents a pairwise relationship between two regions of interest. …”